Biofrontera’s new and updated websites will offer product-related content for both patient and healthcare professional-focused audiences.
Fremont, California: “The launch of these websites, which as part of broader campaigns have been developed and tested with external audiences, marks an important step in our initiative to improve medical affairs and build brand awareness.” comments Erica Monaco, CEO of Biofrontera Inc. Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatological treatments, has launched new and updated websites for Ameluz® and Xepi®, two of its products. Each brand now has two websites, one for patients and the other for healthcare professionals (HCP), with content adapted to both audiences.
“A full team of Biofrontera employees provided multi-disciplinary input into building our new brand-specific websites, featuring new content and engaging graphics. Expanding our digital footprint with a patient-centric landing page is a first for Ameluz® and a significant upgrade for Xepi® which provides useful tools and guidance to patients and prescribers to improve access, knowledge and reimbursement Educating the industry on the importance of therapy of field and the effectiveness of our products is an essential element of our market expansion and our commercial strategy which we believe will increase the use of photodynamic therapy (PDT)”, adds Monaco.
The new websites have design, content and functionality that make it easier for patients to access information and highlight the benefits of the products for prescribers. The Xepi® patient website provides simple instructions for obtaining Xepi® at specific pharmacies using the applicable co-pay system. The Ameluz® website is the first-ever patient-focused website for the drug, and it offers patients a comprehensive description of actinic keratosis (AK) and the Ameluz® treatment, as well as prescribing information and a downloadable brochure .
The Xepi® site includes an access map and a sample request form for healthcare professionals. The Ameluz® HCP website highlights the benefits of field treatment with PDT for AK, as well as the first commercial overview of the RhodoLED® XL illumination lamp and physician support information on access and reimbursement.